Blum Holdings (Blum Holdings) ROCE % : 0.00% (As of Sep. 2023)

View and export this data going back to 2011. Start your Free Trial

What is Blum Holdings ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Blum Holdings's annualized ROCE % for the quarter that ended in Sep. 2023 was 0.00%.

Blum Holdings ROCE % Historical Data

The historical data trend for Blum Holdings's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Blum Holdings ROCE % Chart

Blum Holdings Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

ROCE %

Get a 7-Day Free Trial

-28.50

-34.03

-7.99

-30.55

-231.40

Blum Holdings Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
ROCE %	Get a 7-Day Free Trial															-1,169.73	-	-	-	-

Blum Holdings ROCE % Calculation

Blum Holdings's annualized ROCE % for the fiscal year that ended in Dec. 2022 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2022 )		(A: Dec. 2021 )		(A: Dec. 2022 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2022 )		(A: Dec. 2021 )		(A: Dec. 2022 )
	=	-191.461	/	( ( (271.824 - 87.708)	+	(40.508 - 59.143) )	/ 2 )
	=	-191.461	/	( (184.116	+	-18.635)	/ 2 )
	=	-191.461	/	82.7405
	=	-231.40 %

Blum Holdings's ROCE % of for the quarter that ended in Sep. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Sep. 2023 )		(Q: Jun. 2023 )		(Q: Sep. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Sep. 2023 )		(Q: Jun. 2023 )		(Q: Sep. 2023 )
	=	-8.436	/	( ( (38.26 - 52.816)	+	(36.531 - 59.037) )	/ 2 )
	=	-8.436	/	( ( -14.556	+	-22.506 )	/ 2 )
	=	-8.436	/	-18.531
	=	0 %

(1) Note: The EBIT data used here is four times the quarterly (Sep. 2023) EBIT data.

Blum Holdings (OTCPK:BLMH) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Blum Holdings ROCE % Related Terms

Thank you for viewing the detailed overview of Blum Holdings's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Blum Holdings (Blum Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Blum Holdings Inc (OTCPK:BLMH) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

3242 South Halladay Street, Suite 202, Santa Ana, CA, USA, 92705

Website

https://www.unrivaledbrands.com

Blum Holdings Inc formerly Unrivaled Brands Inc is a vertically integrated cannabis multi-state operator having a cannabis brand spanning consumer products, cultivation, distribution, and retail. Its brands include Korova, Sticks, and Cabana, among others. It operates leading dispensaries throughout the state as well as several leading company-owned brands including Korova, known for its high potency products across multiple product categories.

Executives

Patty Chan	officer: CHIEF FINANCIAL OFFICER	11516 DOWNEY AVE, DOWNEY CA 90241
Oren Schauble	officer: President	3242 S HALLADAY ST., SUITE 202, SANTA ANA CA 92705
Dallas Imbimbo	director	1800 NEWPORT CIRCLE, SANTA ANA CA 92705
Eric Baum	director	866 BERKSHIRE DRIVE, WESTBURY NY 11590
Tiffany N. Davis	director	11852 MANHATTAN CT., RANCHO CUCAMONGA CA 91730
Michael Nahass	director	2040 MAIN STREET, SUITE 225, IRVINE CA 92614
Derek Peterson	director, officer: President and CEO	2040 MAIN STREET, SUITE 225, IRVINE CA 92614
Alan David Gladstone	other: Former Director of Issuer	P.O BOX 9699, NEWPORT BEACH CA 92658
Uri Kenig	officer: Chief Operating Officer	2040 MAIN ST., SUITE 225, IRVINE CA 92614
Ira E. Ritter	director	C/O RITTER PHARMACEUTICALS INC., 1801 CENTURY PARK EAST, SUITE 1820, LOS ANGELES CA 90096
Nicholas Kovacevich	director	2618 SAN MIGUEL DRIVE, #480, NEWPORT BEACH CA 92660
Knuettel Ii Francis	director	205 NEWBURY ST, SUITE 204, FRAMINGHAM MA 01701
Jeffrey Robert Batliner	officer: Chief Financial Officer	2040 MAIN STREET, SUITE 225, IRVINE CA 92614
Megan Jimenez	officer: Chief Financial Officer	2040 MAIN ST., SUITE 225, IRVINE CA 92614
Matthew Morgan	director, officer: Chief Executive Officer	2040 MAIN STREET, SUITE 225, IRVINE CA 92614